BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Docket Clock//docket-clock.pages.dev//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:FDA Clinical deadlines (Docket Clock) X-PUBLISHED-TTL:PT12H REFRESH-INTERVAL;VALUE=DURATION:PT12H BEGIN:VEVENT UID:2026-10752-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261026 DTEND;VALUE=DATE:20261027 SUMMARY:FDA comments close: Patient-Focused Drug Development for Nonhealin g Chronic Wounds\; Public Meeting\; Request for Comments DESCRIPTION:Notice. Federal Register 2026-10752. Docket FDA-2026-N-5057. D etails: https://docket-clock.pages.dev/doc/2026-10752/ Official: https:// www.federalregister.gov/documents/2026/05/29/2026-10752/patient-focused-d rug-development-for-nonhealing-chronic-wounds-public-meeting-request-for- comments URL:https://www.federalregister.gov/documents/2026/05/29/2026-10752/patien t-focused-drug-development-for-nonhealing-chronic-wounds-public-meeting-r equest-for-comments TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-18805-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261113 DTEND;VALUE=DATE:20261114 SUMMARY:FDA comments close: Statistical Considerations for the Design of R are Disease Clinical Investigations\; Establishment of a Public Docket\; Request for Information and Comments DESCRIPTION:Notice. Federal Register 2026-18805. Docket FDA-2026-N-10165. Details: https://docket-clock.pages.dev/doc/2026-18805/ Official: https:/ /www.federalregister.gov/documents/2026/09/15/2026-18805/statistical-cons iderations-for-the-design-of-rare-disease-clinical-investigations-establi shment-of-a URL:https://www.federalregister.gov/documents/2026/09/15/2026-18805/statis tical-considerations-for-the-design-of-rare-disease-clinical-investigatio ns-establishment-of-a TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-20427-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261120 DTEND;VALUE=DATE:20261121 SUMMARY:FDA comments close: Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products\; Request for Information DESCRIPTION:Notice. Federal Register 2026-20427. Docket FDA-2026-N-10429. Details: https://docket-clock.pages.dev/doc/2026-20427/ Official: https:/ /www.federalregister.gov/documents/2026/10/06/2026-20427/design-and-safet y-considerations-for-clinical-trials-involving-ibogaine-drug-products-req uest-for URL:https://www.federalregister.gov/documents/2026/10/06/2026-20427/design -and-safety-considerations-for-clinical-trials-involving-ibogaine-drug-pr oducts-request-for TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19849-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261130 DTEND;VALUE=DATE:20261201 SUMMARY:FDA comments close: Agency Information Collection Activities\; Pro posed Collection\; Comment Request\; Protection of Human Subjects and Ins titutional Review Boards DESCRIPTION:Notice. Federal Register 2026-19849. Docket FDA-2026-N-10132. Details: https://docket-clock.pages.dev/doc/2026-19849/ Official: https:/ /www.federalregister.gov/documents/2026/09/29/2026-19849/agency-informati on-collection-activities-proposed-collection-comment-request-protection-o f-human URL:https://www.federalregister.gov/documents/2026/09/29/2026-19849/agency -information-collection-activities-proposed-collection-comment-request-pr otection-of-human TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19349-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261207 DTEND;VALUE=DATE:20261208 SUMMARY:FDA comments close: Nonclinical Testing Terminology DESCRIPTION:Proposed Rule. Federal Register 2026-19349. Docket FDA-2026-N- 5347. Details: https://docket-clock.pages.dev/doc/2026-19349/ Official: h ttps://www.federalregister.gov/documents/2026/09/22/2026-19349/nonclinica l-testing-terminology URL:https://www.federalregister.gov/documents/2026/09/22/2026-19349/noncli nical-testing-terminology TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19350-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261207 DTEND;VALUE=DATE:20261208 SUMMARY:FDA comments close: Nonclinical Testing Terminology DESCRIPTION:Rule. Federal Register 2026-19350. Docket FDA-2026-N-5347. Det ails: https://docket-clock.pages.dev/doc/2026-19350/ Official: https://ww w.federalregister.gov/documents/2026/09/22/2026-19350/nonclinical-testing -terminology URL:https://www.federalregister.gov/documents/2026/09/22/2026-19350/noncli nical-testing-terminology TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-21142-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261211 DTEND;VALUE=DATE:20261212 SUMMARY:FDA comments close: Fit-for-Purpose Rare Disease Framework Initiat ive\; Public Meeting\; Request for Information and Comments DESCRIPTION:Notice. Federal Register 2026-21142. Docket FDA-2026-N-12214. Details: https://docket-clock.pages.dev/doc/2026-21142/ Official: https:/ /www.federalregister.gov/documents/2026/10/16/2026-21142/fit-for-purpose- rare-disease-framework-initiative-public-meeting-request-for-information- and URL:https://www.federalregister.gov/documents/2026/10/16/2026-21142/fit-fo r-purpose-rare-disease-framework-initiative-public-meeting-request-for-in formation-and TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-01903-close@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20261231 DTEND;VALUE=DATE:20270101 SUMMARY:FDA comments close: FDA Rare Disease Innovation Hub Future Program ming\; Request for Comments DESCRIPTION:Notice. Federal Register 2026-01903. Docket FDA-2026-N-0131. D etails: https://docket-clock.pages.dev/doc/2026-01903/ Official: https:// www.federalregister.gov/documents/2026/01/30/2026-01903/fda-rare-disease- innovation-hub-future-programming-request-for-comments URL:https://www.federalregister.gov/documents/2026/01/30/2026-01903/fda-ra re-disease-innovation-hub-future-programming-request-for-comments TRANSP:TRANSPARENT END:VEVENT BEGIN:VEVENT UID:2026-19350-eff@docket-clock.pages.dev DTSTAMP:20261017T145145Z DTSTART;VALUE=DATE:20270204 DTEND;VALUE=DATE:20270205 SUMMARY:FDA effective: Nonclinical Testing Terminology DESCRIPTION:Rule. Federal Register 2026-19350. Docket FDA-2026-N-5347. Det ails: https://docket-clock.pages.dev/doc/2026-19350/ Official: https://ww w.federalregister.gov/documents/2026/09/22/2026-19350/nonclinical-testing -terminology URL:https://www.federalregister.gov/documents/2026/09/22/2026-19350/noncli nical-testing-terminology TRANSP:TRANSPARENT END:VEVENT END:VCALENDAR